Alpha Jonathan Maidment hikes the Pacific Crest Trail

Wednesday, April 11, 2018

This story appears in the Spring 2018 issue of Alpha-1-To-One Magazine. Subscriptions are free. Determined and driven are the first two adjectives that come to mind when you get a grasp of the endeavor that 23-year old Jonathan Maidment has assumed for the last four years. His inspiration knows no boundaries, and his determination has turned every obstacle into a triumph. Back in 2014,...

Click For Search Options

Happy 25th transplant anniversary to Mary Pierce

Monday, April 2, 2018

This is an excerpt of a story that originally appeared in the Spring 2013 issue of Alpha-1-To-One Magazine. Mary Pierce was diagnosed with Alpha-1 on her 40th birthday, Feb. 16, 1987. She’d been home sick from work for about a week...

In honor of Bruce Parker

Friday, March 30, 2018

The Alpha–1 community, including AlphaNet and the Alpha–1 Foundation, is grieving the loss of our friend, and AlphaNet REACH program coordinator Bruce Parker, from Chattanooga, TN. Bruce, who was also an Alpha, parted on March 28, 2018...

Alpha-1-To-One Magazine is in the mail - The true cost of competitive bidding

Thursday, March 22, 2018

This article appears in the Spring 2018 issue of Alpha-1-To-One Magazine. The multiphase competitive bidding program began in January of 2011 with the purpose of ensuring Medicare beneciaries access to quality supplemental oxygen products and...

Spark Therapeutics explores payment options after revealing price tag for first gene therapy in the US

Thursday, January 4, 2018

Philadelphia based pharmaceutical company, Spark Therapeutics, confirmed conversations with the U.S. Centers of Medicare and Medicaid Services on a proposal that would allow for multi-year payment plans for its innovative treatment, Luxturna, the...

Arrowhead Pharmaceuticals submits for regulatory clearance for first-in-human study

Friday, December 29, 2017

Arrowhead Pharmaceuticals Inc. announced that it filed a regulatory submission to begin a first-in-human study of ARO-AAT, a second-generation investigational medicine for the treatment of Alpha-1 liver disease. Pending approval, Arrowhead intends...

ATS renames PAR Excellence Award after John W. Walsh

Wednesday, December 13, 2017

The American Thoracic Society (ATS) Public Advisory Roundtable was moved to rename the annual PAR Excellence Award by a unanimous vote in November. The award, presented at the ATS International Conference, will now be referred to as the...

Alpha-1 research pioneer Jack A. Pierce, MD, passes away

Thursday, December 7, 2017

“One of the early investigators of Alpha–1 and the initial head of the one of the first Pulmonary and Critical Care departments in the country at Washington University in St. Louis has died at the age of 92. I believe few of...

Recruitment begins for gene therapy clinical trial for Alpha-1 Antitrypsin Deficiency

Tuesday, December 5, 2017

Enrollment for a trial for a new treatment for Alpha–1 related lung disease begins today. Adverum Biotechnologies, in partnership with the Alpha–1 Foundation will be recruiting patients, as well as healthy ZZ and Znull...

Your helping hand has an impact for Alphas worldwide

Friday, December 1, 2017

When you donate to the Alpha–1 Foundation, you are helping Alphas everywhere by providing support services to newly diagnosed adults and children, giving access to education to both Alphas and medical professionals, allowing for family...

UK company acquires license for a potential pill-based Alpha–1 lung therapy

Wednesday, November 1, 2017

Mereo BioPharma Group, a clinical stage, UK-based, biopharmaceutical company focused on rare and specialty diseases, announced that it has reached an agreement with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an...

Uncertainty added to health insurance markets

Friday, October 13, 2017

It has been an eventful 24 hours in Washington as President Trump made a number of announcements related to health insurance policy. First, he signed an executive order that seeks to increase competition by facilitating access to association...

Celebrating plasma donors worldwide

Wednesday, October 11, 2017

International Plasma Awareness Week (IPAW) brings awareness to the importance of plasma donors worldwide. “During PPTA’s International Plasma Awareness Week, we want to thank all the donors that make life sustaining Alpha–1...